BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
238 results:

  • 1. Metformin exhibits antineoplastic effects on pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.
    Ruiz-Mitjana A; Vidal-Sabanés M; Navaridas R; Perramon-Güell A; Yeramian A; Nicholson-Sabaté N; Egea J; Encinas M; Matias-Guiu X; Dolcet X
    Biomed Pharmacother; 2023 Dec; 168():115817. PubMed ID: 37925934
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Fertility-preserving treatment outcomes in endometrial cancer and atypical hyperplasia patients with different molecular profiles].
    Shao WY; Dong YT; Lyu QY; Liao JB; Xue Y; Chen XJ
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):742-754. PubMed ID: 37849255
    [No Abstract]    [Full Text] [Related]  

  • 3. Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.
    Reid K; Camacho-Vanegas O; Pandya D; Camacho SC; Qiao RF; Kalir T; Padron-Rhenals MM; Beddoe AM; Dottino P; Martignetti JA
    Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37848227
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cholesterol biogenesis is a pten-dependent actionable node for the treatment of endocrine therapy-refractory cancers.
    Kaysudu I; Gungul TB; Atici S; Yilmaz S; Bayram E; Guven G; Cizmecioglu NT; Sahin O; Yesiloz G; Haznedaroglu BZ; Cizmecioglu O
    Cancer Sci; 2023 Nov; 114(11):4365-4375. PubMed ID: 37706278
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular biological analysis revealed a case of synchronous endometrial and ovarian cancer with different histological grade as metastatic ovarian cancer from endometrial cancer: Case report and review of literature.
    Yumisashi R; Saito R; Togami S; Kobayashi Y; Kitazono I; Tanimoto A; Kobayashi H
    J Obstet Gynaecol Res; 2023 Nov; 49(11):2766-2770. PubMed ID: 37604499
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Knockdown of miR-24 Suppressed the Tumor Growth of Cervical Carcinoma Through Regulating pten/PI3K/AKT Signaling Pathway.
    He H; Lin C; Lu Y; Wu H
    Biochem Genet; 2024 Apr; 62(2):1277-1290. PubMed ID: 37589947
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis.
    Brown M; Leon A; Kedzierska K; Moore C; Belnoue-Davis HL; Flach S; Lydon JP; DeMayo FJ; Lewis A; Bosse T; Tomlinson I; Church DN
    EMBO Mol Med; 2023 Oct; 15(10):e17094. PubMed ID: 37589076
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
    Kitazawa S; Chiyoda T; Nakamura K; Sakai K; Yoshihama T; Nishio H; Kobayashi Y; Iwata T; Banno K; Yamagami W; Nishihara H; Aoki D
    Int J Clin Oncol; 2023 Nov; 28(11):1554-1562. PubMed ID: 37574505
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Evolving Spectrum of Endometrial Glandular Proliferations With Corded and Hyalinized Features.
    Pors J; Weiel JJ; Ryan E; Longacre TA
    Am J Surg Pathol; 2023 Sep; 47(9):1067-1076. PubMed ID: 37493099
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
    Nigon E; Lefeuvre-Plesse C; Martinez A; Chauleur C; Lortholary A; Favier L; Bats AS; Guille A; AdélaÏde J; Finetti P; de Casteljac V; Provansal M; Mamessier E; Bertucci F; Ray-Coquard I; Sabatier R
    J Transl Med; 2023 Jun; 21(1):408. PubMed ID: 37353806
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Khatami F; Shahriari S; Aminimoghaddam S; Klashami ZN; Farahani MS; Teimoori-Toolabi L; Amoli MM; Asadi M; Rashidi BH
    Epigenomics; 2023 Apr; 15(8):507-516. PubMed ID: 37345350
    [No Abstract]    [Full Text] [Related]  

  • 12. pten mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
    Xue Y; Dong Y; Lou Y; Lv Q; Shan W; Wang C; Chen X
    J Gynecol Oncol; 2023 Jul; 34(4):e53. PubMed ID: 36929579
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
    Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
    BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. miR-19-3p Targets pten to Regulate Cervical cancer Cell Proliferation, Invasion, and Autophagy.
    Wang W; Liu L; Tian Y
    Genet Res (Camb); 2023; 2023():4784500. PubMed ID: 36908850
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Machine learning for genetic prediction of chemotherapy toxicity in cervical cancer.
    Guo L; Wang W; Xie X; Wang S; Zhang Y
    Biomed Pharmacother; 2023 May; 161():114518. PubMed ID: 36906972
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A Case Report.
    Yoshida H; Uno M; Ogimoto K; Kobayashi-Kato M; Tanase Y; Ishikawa M; Kato T
    Int J Gynecol Pathol; 2023 May; 42(3):308-314. PubMed ID: 36811847
    [TBL] [Abstract] [Full Text] [Related]  

  • 17.
    Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
    J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The role of poly (ADP-ribose) glycohydrolase in phosphatase and tensin homolog deficiency endometrial cancer.
    Sun Y; Shi Y; Liu H; Lv C; Zhang A
    J Obstet Gynaecol Res; 2023 Apr; 49(4):1244-1254. PubMed ID: 36759425
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Foxo3a-Mediated DNMT3B Impedes Cervical cancer Cell Proliferation and Migration Capacities through Suppressing pten Promoter Methylation.
    Li H; Yuan Y; Dong H; Wang T; Zhang D; Zhou L; Chen L; He X
    J Invest Surg; 2023 Dec; 36(1):2162170. PubMed ID: 36653180
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. pten mutations as predictive marker for the high-grade endometrial cancer development in slovak women.
    Gbelcová H; Gergely L; Šišovský V; Straka Ľ; Böhmer D; Pastoráková A; Sušienková K; Repiská V; Korbeľ M; Danihel Ľ; Priščáková P
    Physiol Res; 2022 Dec; 71(Suppl 1):S125-S135. PubMed ID: 36592448
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.